Atazanavir

Chemical formula: C₃₈H₅₂N₆O₇  Molecular mass: 704.856 g/mol  PubChem compound: 148192

Active ingredient description

Atazanavir is an azapeptide HIV-1 protease inhibitor (PI). The compound selectively inhibits the virus-specific processing of viral Gag-Pol proteins in HIV-1 infected cells, thus preventing formation of mature virions and infection of other cells.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J05AE08 Atazanavir J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AE Protease inhibitors
Discover more medicines within J05AE08

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
REYATAZ Hard capsules European Medicines Agency (EU) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 198904-31-3
DrugBank Drug: DB01072
KEGG Drug: D07471
PubChem Compound: 148192
RxNorm Ingredient: 343047
SNOMED-CT Concept: 413592000
Atazanavir (substance)
UNII Identifier: QZU4H47A3S
ATAZANAVIR

Medicines

Atazanavir is an active ingredient of these brands:

United States (US)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Australia (AU)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Austria (AT)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Brazil (BR)

Canada (CA)

Croatia (HR)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Finland (FI)

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

France (FR)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Hong Kong (HK)

Ireland (IE)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Italy (IT)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Japan (JP)

Lithuania (LT)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Romania (RO)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Singapore (SG)

South Africa (ZA)

Spain (ES)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

United Kingdom (UK)

  • REYATAZ as ATAZANAVIR SULFATE

  • (combination) EVOTAZ as ATAZANAVIR SULFATE

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.